Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MinPAC: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer.

NCT03117920 is registered in ClinicalTrials.gov with Minneamrita Therapeutics LLC as lead sponsor.

NCT NCT03117920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03117920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MinPAC: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer.
Lead sponsor
Minneamrita Therapeutics LLC
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2017
Completion date
July 1, 2019
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer